Santiago, Cherry Lyn .
HRN: 28-51-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2026
AMPICILLIN 1GM (VIAL)
02/09/2026
02/16/2026
IV
2g
Q6h
Thinly MSAF
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines